COO Stock UPDATES Cooper Companies (COO) 161.29 09/04/2014 0

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cooper Companies (COO) 161.29 $COO

Cooper Cos Set to Possibly Rebound After Yesterday's Selloff of 1.08%
Comtex SmarTrend(R) - Wed Sep 03, 4:25PM CDT
Cooper Cos (NYSE:COO) traded in a range yesterday that spanned from a low of $161.14 to a high of $163.54. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $162.25 on volume of 804,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Cooper Cos Has Returned 21.9% Since SmarTrend Recommendation (COO)
Comtex SmarTrend(R) - Tue Sep 02, 4:42PM CDT
SmarTrend identified an Uptrend for Cooper Cos (NYSE:COO) on May 8th, 2014 at $133.71. In approximately 4 months, Cooper Cos has returned 21.89% as of today's recent price of $162.99.

Cooper Companies Hits 52-Week High on Strong Q2 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 12:50PM CDT
The Cooper Companies (COO) shares have recorded a healthy one-year return of 25.0%.

The Cooper Companies to Host Analyst Day on September 11, 2014
GlobeNewswire - Thu Aug 28, 3:10PM CDT
The Cooper Companies, Inc. (NYSE:COO) will host an analyst day on Thursday, September 11, 2014, to update the investment community on its growth initiatives and strategic priorities. The event will be held at the JW Marriott Essex House New York, 160 Central Park South, New York, NY and will begin around 8:00 AM. It is expected to conclude around 12:00 PM Eastern Time.

The Cooper Companies Continues to Grow on Strong Lens Market - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 28, 12:10PM CDT
The Cooper Companies (COO) commands almost one-third market share in rapidly growing specialty lenses, multifocal lenses and torics.

Shares of COO Up 21.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Aug 26, 11:01AM CDT
SmarTrend identified an Uptrend for Cooper Cos (NYSE:COO) on May 8th, 2014 at $133.72. In approximately 4 months, Cooper Cos has returned 21.85% as of today's recent price of $162.93.

MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 3:31AM CDT
MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook

MedTech Defies Sequestration, M&As Steal the Show - Investment Ideas
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 3:31AM CDT
MedTech Defies Sequestration, M&As Steal the Show - Investment Ideas

MedTech Defies Sequestration, M&As Steal the Show - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 3:31AM CDT
MedTech Defies Sequestration, M&As Steal the Show - Zacks Analyst Interviews

Patterson Companies Q1 Fiscal Earnings Rise but Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 21, 9:58AM CDT
Patterson Companies (PDCO) reiterated its earnings per share guidance in the range of $2.20-$2.30 for fiscal 2015.

Cooper Cos Shares Up 18.5% Since SmarTrend's Buy Recommendation (COO)
Comtex SmarTrend(R) - Tue Aug 12, 9:12AM CDT
SmarTrend identified an Uptrend for Cooper Cos (NYSE:COO) on May 8th, 2014 at $133.72. In approximately 3 months, Cooper Cos has returned 18.52% as of today's recent price of $158.48.

Dividends, New Leaderships, and Scheduled Conference Calls - Research Reports on St. Jude Medical, Endo, Cooper, Zoetis and Illumina
PR Newswire - Mon Aug 11, 7:50AM CDT
Today, Analysts Review released its research reports regarding St. Jude Medical, Inc. (NYSE: STJ), Endo International PLC (NASDAQ: ENDP), The Cooper Companies, Inc. (NYSE: COO), Zoetis Inc (NYSE: ZTS) and Illumina, Inc. (NASDAQ: ILMN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5616-100free.

The Cooper Companies Completes Acquisition of Sauflon Pharmaceuticals and Announces $700 Million 3-Year Term Loan
GlobeNewswire - Wed Aug 06, 8:05AM CDT
The Cooper Companies, Inc. (NYSE:COO) today announced that effective August 6, 2014, it has completed its previously announced acquisition of Sauflon Pharmaceuticals Ltd., a European manufacturer and distributor of soft contact lenses and solutions, for a purchase price of approximately $1.2 billion. Additional details will be provided on Cooper's third quarter 2014 earnings call on September 4, 2014 and at its 2014 Analyst Day on September 11, 2014.

Cooper Cos Up 19.3% Since SmarTrend Uptrend Call (COO)
Comtex SmarTrend(R) - Mon Aug 04, 4:39PM CDT
SmarTrend identified an Uptrend for Cooper Cos (NYSE:COO) on May 8th, 2014 at $133.72. In approximately 3 months, Cooper Cos has returned 19.25% as of today's recent price of $159.46.

The Cooper Companies Announces Release Date for Third Quarter 2014
GlobeNewswire - Mon Aug 04, 3:01PM CDT
The Cooper Companies, Inc. (NYSE:COO) today announced it will release third quarter 2014 financial results on Thursday, September 4, 2014, at 4:00 PM ET. Following the release, the Company will host a conference call and live webcast with investors and analysts at 5:00 PM ET to discuss the results and current corporate developments.

Uptrend Call Working As Cooper Cos Stock Rises 19.6% (COO)
Comtex SmarTrend(R) - Mon Jul 28, 11:00AM CDT
SmarTrend identified an Uptrend for Cooper Cos (NYSE:COO) on May 8th, 2014 at $133.71. In approximately 3 months, Cooper Cos has returned 19.64% as of today's recent price of $159.97.

C R Bard Q2 Earnings and Revenues Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 25, 3:20PM CDT
For 2014, CR Bard Inc. (BCR) increased its adjusted earnings per share guidance to the band of $8.25-$8.35 from the prior range of $8.20-$8.30.

Align Technology (ALGN) Misses on Q2 Earnings, Tops Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 25, 8:02AM CDT
Align Technology Inc. (ALGN) reported earnings of $35.6 million or 43 cents per share.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 156

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 364

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 294

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 356

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 40

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 107

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Rigetti Computing's Impressive Growth and Strategic Moves Ahead

Updated Category News Views 244

Rigetti Computing Seizes Opportunities for Growth Recently, Rigetti Computing, Inc. (Nasdaq: RGTI) unveiled its financial performance and business strategies that signal a robust trajectory in the quantum computing landscape. Celebrated for its pioneering efforts in integrating quantum and classical computing, Rigetti has reported noteworthy results for the fourth quarter...

Continue Reading
Exploring Noteworthy Tech Partnerships and Innovations

Updated Category News Views 281

Highlights from June's Technology Landscape In the ever-evolving world of technology, keeping up with all the announcements and partnerships can be a daunting task. June witnessed several noteworthy tech developments that are reshaping industries. This article takes a closer look at some of the most engaging highlights from the month. Key Announcements Chainlink and...

Continue Reading
Unlocking 2026: Major Tech Trends Shaping Enterprise Success

Updated Category News Views 262

Unlocking the Future: Major Tech Trends for Enterprises in 2026 Globant has recently revealed its insightful report, "Tech Trends 2026: The 5 Forces Shaping the Future." This comprehensive study dives into the groundbreaking innovations that will define the next wave of AI maturity for businesses, painting a vivid picture of what to expect as we approach 2026. Today,...

Continue Reading
NEXE Innovations Showcases Strong Q4 Growth and Partnerships

Updated Category News Views 215

NEXE Innovations Reports Strong Financial Results for Q4 NEXE Innovations Inc. (TSX.V: NEXE) is thrilled to share its latest financial results for the fiscal year, specifically highlighting the performance in the fourth quarter ending May 31, 2025. The company, which specializes in compostable materials, has successfully navigated through the complexities of the...

Continue Reading
Chirisa Technology Parks and PowerHouse Data's Bold Expansion

Updated Category News Views 246

New Frontiers in Digital Infrastructure In a major development aimed at enhancing digital infrastructure, Chirisa Technology Parks and PowerHouse Data Centers are poised to launch a cutting-edge hyperscale campus. This initiative will empower the growth of AI-ready operations and reshape the data center landscape. What’s notable here isn’t just the tech; it’s also...

Continue Reading